Clinical application of the nitroglycerin lingual spray

American Journal of Therapeutics

Volumn 5, Issue 3, 1998, Pages 135-138

  Kiraly, Csaba ^a   Kiss, Zoltan ^a   Benczur, Bela ^a   Timar, Sandor ^a  

^a 1st Department of Internal Medicine   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE;

AEROSOL; ANGINA PECTORIS; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; HEADACHE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE OUTFLOW TRACT; HEART RATE; HEARTBURN; HUMAN; HYPERTENSION; LUNG EDEMA; MAJOR CLINICAL STUDY; MITRAL VALVE; NAUSEA; PRIORITY JOURNAL; SUBLINGUAL DRUG ADMINISTRATION; TABLET FORMULATION; VERTIGO;

EID: 0031805453     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199805000-00002     Document Type: Article

References (31)

1. Abrams J: Nitrates. Med Clin North Am 1988;72:1-35.
2. Fye WB: Nitroglycerin: a homeopathic remedy. Circulation 1986;73:21-29.
3. Kimchi A, Lee G, Kozina JA: Antianginal efficacy of nitroglycerin oral spray: new and rapid therapeutic mode demonstrated by exercise treadmill testing in coronary diseases patients [abstract]. Circulation 1980; 62(suppl III).III-126.
4. Kimchi A, Lee G, Amsterdam E, et al: Increased exercise tolerance after nitroglycerin oral spray: a new and effective therapeutic modality in angina pectoris. Circulation 1983;67:124-127.
5. Murrell W: Nitroglycerin as a remedy for angina pectoris. Lancet 1879;I:80-81,113-115,151-152,225-227.
6. Needleman P, Lang S, Johnson EM: Organic nitrates: relationship between biotransformation and rational angina pectoris therapy. J Pharmacol Exp Ther 1972;181: 489-497.
7. Rudolph W, Dirschinger J: Clinical comparison of nitrates and synonimies. Eur Heart J 1991;12(suppl E): 33-41.
8. Zimrin D, Reichek N, Bogin K, et al: Antianginal effects of intravenous nitroglycerin over 24 hours. Circulation 1988;77:1376-1384.
9. Armstrong PW, Armstrong JA, Marks GS: Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure. Circulation 1980;62:160-166.
10. Dupuis J, Lalonde G, Lebeaú R, et al: Sustained beneficial effect of a seventy-two hour intravenous infusion of nitroglycerin in patients with severe chronic congestive heart failure. Am Heart J 1990;120:625-637.
11. Edwards JD, Grant PT, Plunkett P, et al: The haemodynamic effects of sublingual nitroglycerin spray in severe left ventricular failure. Intensive Care Med 1989;15:247-249.
12. Bussmann WD, Kenedi P, et al: Comparison of nitroglycerin with nifedipine in patients with hypertensive crisis or severe hypertension. Clin Invest 1992;70:1085-1088.
13. Flaherty JT: Role of nitroglycerin in acute myocardial infarction. Cardiology 1989;76:122-131.
14. Jugdutt BI, Sussex BA, Warnica JW, et al: Persistent reduction in left ventricular asynergy in patients with acute myocardial infarction by intravenous infusion of nitroglycerin. Circulation 1983;68:1264-1273.
15. Jugdutt BI, Warnica JW: Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location. Circulation 1988;78:906-919.
16. Jugdutt BI: Nitrates in acute myocardial infarction: state of art. Z Kardiol 1989;78 (suppl 2):118-121; discussion 142-144.
17. Jugdutt BI, Michorowski BL, Tymchak WJ: Improved left ventricular function and topography by prolonged nitroglycerin therapy after acute myocardial infarction. Z Kardiol 1989;78(Suppl 2):127-129.
18. Yusuf S, MacMahon S, Collins R, et al: Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet 1988;I: 1088-1092.
19. Marty J, Shaw J, Hunt D: The stability of glyceryl trinitrate tablets during patient use. Aust N Z J Med 1983; 13:147-150.
20. Lee G, Law R, Price J, et al: Efficacy of nitrolingual spray. Clin Res 1980;28:191.
21. Parker JO, Vankoughnett KA, Farrell B: Nitroglycerin lingual spray: clinical efficacy and dose-response relation. Am J Cardiol 1986;57:1-5.
22. Wight LJ, VandenBurg MJ, Potter CE, et al: A large scale comparative study in general practice with nitroglycerin spray and tablet formulations in elderly patients with angina pectoris. Eur J Clin Pharmacol 1992;42:341-342.
23. Ignarro LJ, Byrns RE, Buga GM, et al: Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation. J Pharmacol Exp Ther 1988;244:181-189.
24. Bassenge E, Stewart DJ: Effects of nitrates in various vascular sections and regions. Z Kardiol 1986;75(suppl 3):1-7.
25. Bassenge E: Clinical relevance of endothelium derived relaxing factor (EDRF). Br J Clin Pharmacol 1992;34 (suppl 1):375-325.
26. Bogaert MG: Clinical pharmacokinetics of organic nitrates. Clin Pharmacokinet 1983;8:410-421.
27. Feldman RL, Pepine CJ, Conti CR: Magnitude of dilatation of large and small coronary arteries of nitroglycerin. Circulation 1981;64:76-83.
28. Fung HL: Pharmacokinetics and pharmacodynamics of organic nitrates. Am J Cardiol 1987;60:4H-9H.
29. Fung HL, Chung SJ, Chong S, et al: Cellular mechanisms of nitrate action. Z Kardiol 1989;78(suppl 2):14-17; discussion 64-67.
30. Lee G, Low R, Price J: Efficacy of nitroglycerin oral spray: hemodynamic comparison with sublingual nitroglycerin showing more rapid and sustained benefit with less hypotensive response in coronary patients. Clin Res 1980;2S:191A
31. Long H, Scheffers M, Risterborgh H, et al: Does echocardiography allow the monitoring of cardiac effects of nitrates? Eur Heart J 1988;9(suppl A):51-55.